Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vito Lorusso

Showing results (91-100 of 218) with videos related to

Pageof 22
Sort By:
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|March 1, 2015
Efficacy and safety of oral palonosetron compared with IV palonosetron administered with dexamethasone for the prevention of chemotherapy-induced nausea and vomiting (CINV) in patients with solid tumors receiving cisplatin-based highly emetogenic chemotherapy (HEC)Meinolf Karthaus, Csőszi Tibor, Vito Lorusso, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|November 22, 2011
Lapatinib/Paclitaxel polyelectrolyte nanocapsules for overcoming multidrug resistance in ovarian cancerDaniele Vergara, Claudia Bellomo, Xingcai Zhang, et al.
Molecular and Clinical Oncology|July 24, 2014
Health resource utilisation associated with skeletal-related events in European patients with lung cancer: Α subgroup analysis from a prospective multinational studyVito Lorusso, Ignacio Duran, Cristina Garzon-Rodriguez, et al.
Endocrine|February 9, 2018
Practical issues for the management of hyponatremia in oncologyRossana Berardi, Andrea Antonuzzo, Livio Blasi, et al.
Urologia Internationalis|February 21, 2021
A Novel Artificial Urinary Sphincter (VICTO®) for the Management of Postprostatectomy Urinary Incontinence: Description of the Surgical Technique and Preliminary Results from a Multicenter SeriesAlessandro Giammò, Marco Falcone, Gideon Blecher, et al.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|March 15, 2021
Decision support systems for the prediction of lymph node involvement in early breast cancerRaffaella Massafra, Domenico Pomarico, Daniele La Forgia, et al.
Cancer|June 11, 2005
Capecitabine plus oxaliplatin for the first-line treatment of elderly patients with metastatic colorectal carcinoma: final results of the Southern Italy Cooperative Oncology Group Trial 0108Pasquale Comella, Donato Natale, Antonio Farris, et al.
Lung Cancer (Amsterdam, Netherlands)|March 1, 2008
Cisplatin plus weekly vinorelbine versus cisplatin plus vinorelbine on days 1 and 8 in advanced non-small cell lung cancer: a prospective randomized phase III trial of the G.O.I.M. (Gruppo Oncologico Italia Meridionale)Vittorio Gebbia, Domenico Galetta, Vito Lorusso, et al.
Cancer Biomarkers : Section a of Disease Markers|June 1, 2014
Predictive factors to targeted treatment in gastrointestinal carcinomasNicola Silvestris, Ilaria Marech, Anna Elisabetta Brunetti, et al.
International Journal of Molecular Imaging|February 13, 2013
In vivo tracking of murine adipose tissue-derived multipotent adult stem cells and ex vivo cross-validationChiara Garrovo, Natascha Bergamin, Dave Bates, et al.
Pageof 22

Showing results (91-100 of 218) with videos related to

Sort By:
Pageof 22
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|March 1, 2015
Efficacy and safety of oral palonosetron compared with IV palonosetron administered with dexamethasone for the prevention of chemotherapy-induced nausea and vomiting (CINV) in patients with solid tumors receiving cisplatin-based highly emetogenic chemotherapy (HEC)Meinolf Karthaus, Csőszi Tibor, Vito Lorusso, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|November 22, 2011
Lapatinib/Paclitaxel polyelectrolyte nanocapsules for overcoming multidrug resistance in ovarian cancerDaniele Vergara, Claudia Bellomo, Xingcai Zhang, et al.
Molecular and Clinical Oncology|July 24, 2014
Health resource utilisation associated with skeletal-related events in European patients with lung cancer: Α subgroup analysis from a prospective multinational studyVito Lorusso, Ignacio Duran, Cristina Garzon-Rodriguez, et al.
Endocrine|February 9, 2018
Practical issues for the management of hyponatremia in oncologyRossana Berardi, Andrea Antonuzzo, Livio Blasi, et al.
Urologia Internationalis|February 21, 2021
A Novel Artificial Urinary Sphincter (VICTO®) for the Management of Postprostatectomy Urinary Incontinence: Description of the Surgical Technique and Preliminary Results from a Multicenter SeriesAlessandro Giammò, Marco Falcone, Gideon Blecher, et al.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|March 15, 2021
Decision support systems for the prediction of lymph node involvement in early breast cancerRaffaella Massafra, Domenico Pomarico, Daniele La Forgia, et al.
Cancer|June 11, 2005
Capecitabine plus oxaliplatin for the first-line treatment of elderly patients with metastatic colorectal carcinoma: final results of the Southern Italy Cooperative Oncology Group Trial 0108Pasquale Comella, Donato Natale, Antonio Farris, et al.
Lung Cancer (Amsterdam, Netherlands)|March 1, 2008
Cisplatin plus weekly vinorelbine versus cisplatin plus vinorelbine on days 1 and 8 in advanced non-small cell lung cancer: a prospective randomized phase III trial of the G.O.I.M. (Gruppo Oncologico Italia Meridionale)Vittorio Gebbia, Domenico Galetta, Vito Lorusso, et al.
Cancer Biomarkers : Section a of Disease Markers|June 1, 2014
Predictive factors to targeted treatment in gastrointestinal carcinomasNicola Silvestris, Ilaria Marech, Anna Elisabetta Brunetti, et al.
International Journal of Molecular Imaging|February 13, 2013
In vivo tracking of murine adipose tissue-derived multipotent adult stem cells and ex vivo cross-validationChiara Garrovo, Natascha Bergamin, Dave Bates, et al.
Pageof 22